Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials (Q91853)

From MaRDI portal
Revision as of 16:42, 25 April 2024 by Import240425040427 (talk | contribs) (Added link to MaRDI item.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials
scientific article

    Statements

    volume
    31
    0 references
    issue
    6
    0 references
    page(s)
    572-578
    0 references
    publication date
    November 2010
    0 references
    author
    A.P. Mander
    0 references
    S.G. Thompson
    0 references
     
    Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Item:Q91853&oldid=33781982"
    Powered by MediaWiki